SERPINE1 and cancer: Xu Z et al. conducted a pan-cancer analysis concerning SERPINE1 and revealed that aberrant expression of SERPINE1 is common in cancers and is associated with poor patient prognosis, impaired cancer immunity, immunotherapy and chemotherapy resistance [50–53].